India-based Mylab Discovery has become the first company in the country to receive approval for its coronavirus (Covid-19) diagnostic test kits, called reverse transcription polymerase chain reaction (RT-PCR) tests.
The testing kit has been commercially approved by the Indian FDA / Central Drugs Standard Control Organisation (CDSCO).
The approval is expected to help increase testing in the country.
RT-PCR kits can study 1000 samples from large labs and 200 from smaller labs.
Mylab expects to produce one lakh test kits per week and then gradually increase the production to meet the testing demands.
Discussion about this post